Taking everything into account, HCWB scores 1 out of 10 in our fundamental rating. HCWB was compared to 525 industry peers in the Biotechnology industry. HCWB has a bad profitability rating. Also its financial health evaluation is rather negative. HCWB does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

In the past year HCWB has reported negative net income.
HCWB had a negative operating cash flow in the past year.
HCWB had negative earnings in each of the past 5 years.
HCWB had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

HCWB's Return On Assets of -88.48% is on the low side compared to the rest of the industry. HCWB is outperformed by 71.62% of its industry peers.

		Industry Rank	Sector Rank
ROA	-88.48%
ROE	N/A
ROIC	N/A

ROA(3y)-72.68%

ROA(5y)-57.6%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

HCWB's Gross Margin of 21.41% is fine compared to the rest of the industry. HCWB outperforms 72.19% of its industry peers.
The Profit Margin and Operating Margin are not available for HCWB so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	21.41%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

HCWB does not have a ROIC to compare to the WACC, probably because it is not profitable.
HCWB has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, HCWB has more shares outstanding
HCWB has a worse debt/assets ratio than last year.

2.2 Solvency

HCWB has an Altman-Z score of -8.67. This is a bad value and indicates that HCWB is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of HCWB (-8.67) is worse than 69.52% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-8.67

ROIC/WACCN/A

WACC7.52%

2.3 Liquidity

HCWB has a Current Ratio of 0.06. This is a bad value and indicates that HCWB is not financially healthy enough and could expect problems in meeting its short term obligations.
HCWB's Current ratio of 0.06 is on the low side compared to the rest of the industry. HCWB is outperformed by 95.05% of its industry peers.
HCWB has a Quick Ratio of 0.06. This is a bad value and indicates that HCWB is not financially healthy enough and could expect problems in meeting its short term obligations.
The Quick ratio of HCWB (0.06) is worse than 95.05% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.06
Quick Ratio	0.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 65.10% over the past year.
HCWB shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -87.80%.

EPS 1Y (TTM)65.1%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%51.09%

Revenue 1Y (TTM)-87.8%

Revenue growth 3YN/A

Revenue growth 5YN/A

Sales Q2Q%-0.09%

3.2 Future

HCWB is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.62% yearly.
The Revenue is expected to grow by 109.56% on average over the next years. This is a very strong growth

EPS Next Y79.82%

EPS Next 2Y33.43%

EPS Next 3Y23.44%

EPS Next 5Y13.62%

Revenue Next Year-23.55%

Revenue Next 2Y-41.42%

Revenue Next 3Y-25.99%

Revenue Next 5Y109.56%

3.3 Evolution

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for HCWB. In the last year negative earnings were reported.
Also next year HCWB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.